Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A., and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| DXCM | DEXCOM INC | 2026-04-02 18:31:59 | 63.3 | 1.08 | 1.74 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DXCM | 0001093557 | DEXCOM INC | US2521311074 | 549300YSK3QDSFR5EU59 | 330857544 | Nasdaq | 3841 | Surgical & Medical Instruments & Apparatus | 1231 | DE | 6340 SEQUENCE DRIVE | SAN DIEGO | CA | 92121 | UNITED STATES | US | 8582000200 | 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121 | 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121 | — | — | 1999 | Leach | 11,100 | http://dexcom.com | 34,200,000,000 | 410,700,000 | 384,864,842 | Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A., and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland. | 2026-04-02 15:36:33 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 34,200,000,000 | -11,100,000,000 | -24.5033 | 384,864,842 | -5,907,176 | -1.5117 |
| 2024 | 45,300,000,000 | -4,100,000,000 | -8.2996 | 390,772,018 | 5,256,597 | 1.3635 |
| 2023 | 49,400,000,000 | 20,300,000,000 | 69.7595 | 385,515,421 | -898,269 | -0.2325 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Michael J. Brownevp | Chief Legal Officer | 2024 | 596,886 | 0 | 4,357,659 | 0 | 10,350 | 4,964,895 |
| Jacob S. Leachevp | Chief Operating Officer | 2024 | 682,498 | 0 | 5,229,163 | 0 | 10,610 | 5,922,271 |
| Kevin R. Sayer | Chief Executive Officer, Chairperson, President | 2024 | 1,157,254 | 0 | 14,536,111 | 0 | 135,432 | 15,828,797 |
| Jereme M. Sylvainevp | Chief Financial Officer | 2024 | 609,323 | 0 | 5,229,163 | 0 | 12,626 | 5,851,112 |
| Sadie M. Sternevp | Chief Human Resources Officer | 2024 | 539,791 | 0 | 4,357,659 | 0 | 11,038 | 4,908,488 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 11,100 |
| 2024 | 10,300 |
| 2023 | 9,600 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 4,662,000,000 | 4,033,000,000 | 3,622,300,000 |
| Cost Of Revenue | 1,860,100,000 | 1,594,800,000 | 1,333,400,000 |
| Gross Profit | 2,801,900,000 | 2,438,200,000 | 2,288,900,000 |
| Research And Development Expenses | 599,100,000 | 552,400,000 | 505,800,000 |
| General And Administrative Expenses | 1,291,000,000 | 1,285,800,000 | 1,185,400,000 |
| Operating Expenses | 1,890,100,000 | 1,838,200,000 | 1,691,200,000 |
| Operating Income | 911,800,000 | 600,000,000 | 597,700,000 |
| Net Income | 836,300,000 | 576,200,000 | 541,500,000 |
| Earnings Per Share Basic | 2.14 | 1.46 | 1.4 |
| Earnings Per Share Diluted | 2.09 | 1.42 | 1.3 |
| Weighted Average Shares Outstanding Basic | 390,200,000 | 393,600,000 | 386,000,000 |
| Weighted Average Shares Outstanding Diluted | 405,500,000 | 412,700,000 | 425,500,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 917,700,000 | 606,100,000 | 566,300,000 |
| Marketable Securities Current | — | 1,730,000,000 | 2,160,000,000 |
| Accounts Receivable | 1,216,100,000 | 1,005,700,000 | 973,900,000 |
| Inventories | 629,100,000 | 542,600,000 | 559,600,000 |
| Non Trade Receivables | 60,800,000 | 27,900,000 | 13,600,000 |
| Other Assets Current | 29,200,000 | 39,700,000 | 49,300,000 |
| Total Assets Current | 4,033,300,000 | 4,301,400,000 | 4,425,900,000 |
| Marketable Securities Non Current | 218,000,000 | 247,700,000 | 38,500,000 |
| Property Plant And Equipment | — | — | — |
| Other Assets Non Current | 278,700,000 | 173,000,000 | 75,000,000 |
| Total Assets Non Current | 1,637,300,000 | 1,402,700,000 | 1,184,500,000 |
| Total Assets | 6,339,900,000 | 6,484,500,000 | 6,264,500,000 |
| Accounts Payable | 344,300,000 | 345,300,000 | 276,400,000 |
| Deferred Revenue | — | 8,000,000 | 18,400,000 |
| Short Term Debt | — | — | — |
| Other Liabilities Current | 7,700,000 | 3,900,000 | 7,500,000 |
| Total Liabilities Current | 2,142,500,000 | 2,932,000,000 | 1,556,000,000 |
| Long Term Debt | — | — | — |
| Other Liabilities Non Current | 137,100,000 | 147,900,000 | 125,600,000 |
| Total Liabilities Non Current | 1,451,400,000 | 1,449,900,000 | 2,639,900,000 |
| Total Liabilities | 3,593,900,000 | 4,381,900,000 | 4,195,900,000 |
| Common Stock | 400,000 | 400,000 | 400,000 |
| Retained Earnings | 2,433,900,000 | 1,597,600,000 | 1,021,400,000 |
| Accumulated Other Comprehensive Income | 115,000,000 | -8,000,000 | -16,700,000 |
| Total Shareholders Equity | 2,746,000,000 | 2,102,600,000 | 2,068,600,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 39,500,000 | 39,900,000 | 186,000,000 |
| Share Based Compensation Expense | 159,600,000 | 170,400,000 | 150,800,000 |
| Other Non Cash Income Expense | 21,800,000 | 47,300,000 | 83,900,000 |
| Change In Accounts Receivable | 201,900,000 | 35,000,000 | 260,100,000 |
| Change In Inventories | 63,700,000 | -12,400,000 | 252,600,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 347,000,000 | 211,700,000 | 466,500,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 1,440,700,000 | 989,500,000 | 748,500,000 |
| Purchases Of Marketable Securities | 1,246,600,000 | 2,576,300,000 | 3,200,400,000 |
| Sales Of Marketable Securities | 2,164,700,000 | 2,824,400,000 | 2,947,400,000 |
| Acquisition Of Property Plant And Equipment | 363,500,000 | 358,800,000 | 236,600,000 |
| Acquisition Of Business | — | 0 | 0 |
| Other Investing Activities | -600,000 | 15,500,000 | 17,600,000 |
| Cash From Investing Activities | 536,000,000 | -207,500,000 | -507,200,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 28,100,000 | 28,200,000 | 26,600,000 |
| Repurchase Of Common Stock | 500,000,000 | 750,000,000 | 688,700,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | -7,000,000 | -13,000,000 | 1,500,000 |
| Cash From Financing Activities | -1,686,400,000 | -734,800,000 | -318,600,000 |
| Change In Cash | 311,800,000 | 39,800,000 | -75,800,000 |
| Cash At End Of Period | 917,700,000 | 606,100,000 | 566,300,000 |
| Income Taxes Paid | 94,400,000 | 198,000,000 | 212,300,000 |
| Interest Paid | 11,400,000 | 11,400,000 | 12,400,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 2.14 | 1.46 | 1.4 |
| Price To Earnings Ratio | 31.014 | 53.2671 | 88.6357 |
| Earnings Growth Rate | 46.5753 | 4.2857 | 59.0909 |
| Price Earnings To Growth Ratio | 0.6659 | 12.429 | 1.5 |
| Book Value Per Share | 7.0374 | 5.342 | 5.3591 |
| Price To Book Ratio | 9.431 | 14.5583 | 23.1551 |
| Ebitda | 984,500,000 | 829,000,000 | 960,100,000 |
| Enterprise Value | — | — | — |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | — | — | — |
| Capital Expenditures | — | — | — |
| Free Cash Flow | — | — | — |
| Return On Equity | 0.3046 | 0.274 | 0.2618 |
| One Year Beta | 1.0255 | 0.3864 | 0.9241 |
| Three Year Beta | 0.8553 | 1.1898 | 1.3163 |
| Five Year Beta | 1.1383 | 1.0112 | 1.066 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Brown Michael Jon | EVP, Chief Legal Officer | 2026-03-16 | 1,700 | D | 112,904 |
| Coleman Jon | EVP, Chief Commercial Officer | 2026-03-08 | 43,897 | A | 112,635 |
| Leach Jacob Steven | Director, President, CEO, and Director | 2026-03-08 | 104,516 | A | 441,567 |
| Leach Jacob Steven | Director, President, CEO, and Director | 2026-03-08 | 19,757 | D | 421,810 |
| Stern Sadie | EVP, Chief HR Officer | 2026-03-08 | 39,019 | A | 148,709 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Tina Smith | Senator | 2020-04-16 | Sale (Partial) | 2020-03-17 | Spouse | $250,001 - $500,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Jefferson Shreve | 2025-06-22 | IN06 | Purchase | 2025-05-08 | — | $15,001 - $50,000 |
| Jefferson Shreve | 2025-06-22 | IN06 | Sale | 2025-05-12 | — | $15,001 - $50,000 |
| Rob Bresnahan | 2025-06-09 | PA08 | Purchase | 2025-05-15 | — | $1,001 - $15,000 |
| Jefferson Shreve | 2025-05-08 | IN06 | Sale | 2025-04-07 | — | $15,001 - $50,000 |
| Rob Bresnahan | 2025-04-28 | PA08 | Sale | 2025-04-08 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Coastline Trust Co | 2026-03-31 | 5,024 | 80 | 62.8 |
| Global Wealth Strategies & Associates | 2026-03-31 | 12,560 | 200 | 62.8 |
| Ares Financial Consulting, LLC | 2026-03-31 | 10,353 | 166 | 62.3675 |
| Hilltop National Bank | 2026-03-31 | 61,733 | 983 | 62.8006 |
| Aspect Partners, LLC | 2026-03-31 | 691 | 11 | 62.8182 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Direxion Shares ETF Trust | 2026-01-31 | Direxion Daily S&P 500(R) Bull 2X ETF | SPUU | 1,441 | 105,250.64 | 0.0452 |
| Direxion Shares ETF Trust | 2026-01-31 | Direxion Daily S&P 500(R) Bull 3X ETF | SPXL | 27,146 | 1,982,743.84 | 0.0348 |
| Direxion Shares ETF Trust | 2026-01-31 | Direxion Daily Healthcare Bull 3X ETF | CURE | 8,929 | 652,174.16 | 0.3954 |
| Direxion Shares ETF Trust | 2026-01-31 | Direxion HCM Tactical Enhanced US ETF | HCMT | 3,105 | 226,789.2 | 0.0389 |
| Direxion Shares ETF Trust | 2026-01-31 | Direxion NASDAQ-100(R) Equal Weighted Index ETF | QQQE | 184,039 | 13,442,208.56 | 1.0966 |